Ruchika Goel1,2, Eshan U Patel1, Jodie L White1, Meera R Chappidi1, Paul M Ness1, Melissa M Cushing3, Clifford M Takemoto4, Beth H Shaz5, Steven M Frank6, Aaron A R Tobian1. 1. Department of Pathology, Johns Hopkins University, Baltimore, MD, United States. 2. Division of Hematology/Oncology, Simmons Cancer Institute at SIU School of Medicine, Springfield, IL, United States. 3. Department of Pathology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY, United States. 4. Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States. 5. New York Blood Center, New York, NY, United States. 6. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States.
Abstract
BACKGROUND: Demographic and hospital-level factors associated with red blood cell (RBC), plasma, and platelet transfusions in hospitalized patients across the U.S. are not well characterized. METHODS: We conducted a retrospective analysis of the National Inpatient Sample (2014). The unit of analysis was a hospitalization; sampling weights were applied to generate nationally-representative estimates. The primary outcome was having ≥ 1 RBC transfusion procedure; plasma and platelet transfusions were similarly assessed as secondary outcomes. For each component, factors associated with transfusion were measured using adjusted prevalence ratios (adjPR) and 95% confidence intervals (95% CI) estimated by multivariable Poisson regression. RESULTS: The prevalence of RBC, plasma, and platelet transfusion was 5.8%, 0.9%, and 0.7%, respectively. RBC transfusions were associated with older age (≥ 65 vs. < 18 years; adjPR = 1.80; 95% CI = 1.66-1.96), female sex (adjPR = 1.13; 95% CI = 1.12-1.14), minority race/ethnic status, and hospitalizations in rural hospitals compared to urban teaching hospitals. Prevalence of RBC transfusion was lower among hospitalizations in the Midwest compared to the Northeast (adjPR = 0.73; 95% CI = 0.67-0.80). All components were more likely to be transfused in patients with a primary hematologic diagnosis, patients with a higher number of total diagnoses, patients who experienced a higher number of other procedures, and patients who eventually died in the hospital. In contrast to RBC transfusions, prevalence of platelet transfusion was greater in urban teaching hospitals (vs. rural; adjPR = 1.71; 95% CI = 1.49-1.98) and lower in blacks (vs. whites; adjPR = 0.80; 95% CI = 0.76-0.85). CONCLUSIONS: Nationally, there is heterogeneity in factors associated with transfusion between each blood component, including by hospital type and location. This variability presents patient blood management programs with potential opportunities to reduce transfusions.
BACKGROUND: Demographic and hospital-level factors associated with red blood cell (RBC), plasma, and platelet transfusions in hospitalized patients across the U.S. are not well characterized. METHODS: We conducted a retrospective analysis of the National Inpatient Sample (2014). The unit of analysis was a hospitalization; sampling weights were applied to generate nationally-representative estimates. The primary outcome was having ≥ 1 RBC transfusion procedure; plasma and platelet transfusions were similarly assessed as secondary outcomes. For each component, factors associated with transfusion were measured using adjusted prevalence ratios (adjPR) and 95% confidence intervals (95% CI) estimated by multivariable Poisson regression. RESULTS: The prevalence of RBC, plasma, and platelet transfusion was 5.8%, 0.9%, and 0.7%, respectively. RBC transfusions were associated with older age (≥ 65 vs. < 18 years; adjPR = 1.80; 95% CI = 1.66-1.96), female sex (adjPR = 1.13; 95% CI = 1.12-1.14), minority race/ethnic status, and hospitalizations in rural hospitals compared to urban teaching hospitals. Prevalence of RBC transfusion was lower among hospitalizations in the Midwest compared to the Northeast (adjPR = 0.73; 95% CI = 0.67-0.80). All components were more likely to be transfused in patients with a primary hematologic diagnosis, patients with a higher number of total diagnoses, patients who experienced a higher number of other procedures, and patients who eventually died in the hospital. In contrast to RBC transfusions, prevalence of platelet transfusion was greater in urban teaching hospitals (vs. rural; adjPR = 1.71; 95% CI = 1.49-1.98) and lower in blacks (vs. whites; adjPR = 0.80; 95% CI = 0.76-0.85). CONCLUSIONS: Nationally, there is heterogeneity in factors associated with transfusion between each blood component, including by hospital type and location. This variability presents patient blood management programs with potential opportunities to reduce transfusions.
Authors: John D Roback; Stephen Caldwell; Jeff Carson; Robertson Davenport; Mary Jo Drew; Anne Eder; Mark Fung; Marilyn Hamilton; John R Hess; Naomi Luban; Jeremy G Perkins; Bruce S Sachais; Aryeh Shander; Toby Silverman; Ed Snyder; Christopher Tormey; John Waters; Ben Djulbegovic Journal: Transfusion Date: 2010-03-19 Impact factor: 3.157
Authors: Susan R Heckbert; Charles Kooperberg; Monika M Safford; Bruce M Psaty; Judith Hsia; Anne McTiernan; J Michael Gaziano; William H Frishman; J David Curb Journal: Am J Epidemiol Date: 2004-12-15 Impact factor: 4.897
Authors: Ruchika Goel; Meera R Chappidi; Eshan U Patel; Paul M Ness; Melissa M Cushing; Steven M Frank; Aaron A R Tobian Journal: JAMA Date: 2018-02-27 Impact factor: 56.272
Authors: Katherine D Ellingson; Mathew R P Sapiano; Kathryn A Haass; Alexandra A Savinkina; Misha L Baker; Koo-Whang Chung; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju Journal: Transfusion Date: 2017-06 Impact factor: 3.157
Authors: Nareg H Roubinian; Gabriel J Escobar; Vincent Liu; Marla N Gardner; Jeffrey L Carson; Steven H Kleinman; Edward L Murphy Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Eshan U Patel; Evan M Bloch; Mary K Grabowski; Ruchika Goel; Parvez M Lokhandwala; Patricia A R Brunker; Jodie L White; Beth Shaz; Paul M Ness; Aaron A R Tobian Journal: Transfusion Date: 2019-06-20 Impact factor: 3.157
Authors: Ruchika Goel; Cassandra D Josephson; Eshan U Patel; Molly R Petersen; Zoe Packman; Eric Gehrie; Evan M Bloch; Parvez Lokhandwala; Paul M Ness; Louis Katz; Marianne Nellis; Oliver Karam; Aaron A R Tobian Journal: Transfusion Date: 2020-06-26 Impact factor: 3.157
Authors: Meghan Delaney; Oliver Karam; Lani Lieberman; Katherine Steffen; Jennifer A Muszynski; Ruchika Goel; Scot T Bateman; Robert I Parker; Marianne E Nellis; Kenneth E Remy Journal: Pediatr Crit Care Med Date: 2022-01-01 Impact factor: 3.971
Authors: Ruchika Goel; Molly R Petersen; Eshan U Patel; Zoe Packman; Evan M Bloch; Eric A Gehrie; Parvez M Lokhandwala; Paul M Ness; Beth Shaz; Louis M Katz; Steven M Frank; Aaron A R Tobian Journal: Transfusion Date: 2020-08-31 Impact factor: 3.157